Xbrane Biopharma and Intas Pharmaceuticals Join Forces to Develop Biosimilar of Opdivo (Nivolumab)
Shots: Xbrane and Intas have entered into a global licensing and co-development ag...
Samsung Bioepis and Biogen Report the EC’s Approval of Opuviz (Biosimilar, Eylea)
Shots: The EC has granted approval to Opuviz 40 mg/mL solution, biosimilar version...
Alvotech and Advanz Pharma Reports the EMA’s MAA Acceptance of AVT05 (Biosimilar, Simponi)
Shots: The EMA has accepted the MAA of AVT05, biosimilar version of J&J's...
Meitheal Pharmaceuticals Receives Exclusive Commercial Rights of Three Biosimilars Across the US
Shots: Meitheal Pharmaceuticals & its parent, Hong Kong King-Friend Industry (...
Alvotech and Teva Reports the US FDA’s Approval for the Additional Presentation of Selarsdi (Biosimilar, Stelara)
Shots: Alvotech and Teva have received the US FDA’s approval of Selarsdi&rsq...
Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)
Shots: Following the MAA submission by Accord Healthcare (Intas’ subsidiary)...
